Travere Therapeutics, Inc. (TVTX) Social Stream
TRAVERE THERAPEUTICS INC (TVTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering TRAVERE THERAPEUTICS INC.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-12-15 | 7 | $45 | $20 | $37 | $8.64 | 328.24% |
2021-12-16 | 7 | $45 | $20 | $37.833 | $8.64 | 337.88% |
2022-01-10 | 7 | $45 | $25 | $38.666 | $8.64 | 347.52% |
2022-01-25 | 7 | $45 | $27 | $39 | $8.64 | 351.39% |
2022-02-25 | 7 | $45 | $27 | $37 | $8.64 | 328.24% |
2022-02-28 | 6 | $45 | $27 | $40.285 | $8.64 | 366.26% |
2022-03-10 | 5 | $45 | $27 | $39.5 | $8.64 | 357.18% |
2022-04-20 | 8 | $45 | $27 | $39.857 | $8.64 | 361.31% |
2022-04-25 | 8 | $45 | $27 | $40.714 | $8.64 | 371.23% |
2022-04-28 | 8 | $45 | $24 | $40.875 | $8.64 | 373.09% |
2022-05-06 | 8 | $45 | $24 | $40.5 | $8.64 | 368.75% |
2022-05-16 | 8 | $45 | $24 | $40.25 | $8.64 | 365.86% |
2022-05-17 | 8 | $46 | $24 | $40.375 | $8.64 | 367.3% |
2022-06-02 | 8 | $46 | $24 | $39.714 | $8.64 | 359.65% |
2022-06-08 | 8 | $46 | $24 | $39.571 | $8.64 | 358% |
2022-06-13 | 8 | $47 | $24 | $40.142 | $8.64 | 364.61% |
2022-07-26 | 9 | $47 | $25 | $40.625 | $8.64 | 370.2% |
2022-08-04 | 9 | $46 | $25 | $40.625 | $8.64 | 370.2% |
2022-08-08 | 9 | $45 | $25 | $39.375 | $8.64 | 355.73% |
2022-09-17 | 9 | $45 | $25 | $39.125 | $8.64 | 352.84% |
2022-10-17 | 9 | $45 | $24 | $38 | $8.64 | 339.81% |
2022-10-21 | 9 | $43 | $24 | $37.125 | $8.64 | 329.69% |
2022-10-28 | 9 | $44 | $24 | $37.25 | $8.64 | 331.13% |
2022-11-03 | 9 | $44 | $24 | $37.125 | $8.64 | 329.69% |
2022-12-05 | 10 | $44 | $24 | $36.111 | $8.64 | 317.95% |
2022-12-14 | 11 | $44 | $22 | $34.111 | $8.64 | 294.8% |
2023-01-26 | 10 | $44 | $22 | $34.666 | $8.64 | 301.23% |
2023-01-30 | 10 | $44 | $22 | $34.444 | $8.64 | 298.66% |
2023-02-01 | 10 | $44 | $22 | $34.555 | $8.64 | 299.94% |
2023-02-16 | 10 | $50 | $22 | $35.222 | $8.64 | 307.66% |
2023-02-21 | 11 | $52 | $23 | $37.7 | $8.64 | 336.34% |
2023-02-26 | 11 | $52 | $23 | $37.5 | $8.64 | 334.03% |
2023-02-28 | 10 | $52 | $23 | $37.3 | $8.64 | 331.71% |
2023-03-01 | 12 | $52 | $23 | $37.272 | $8.64 | 331.39% |
2023-03-14 | 12 | $52 | $23 | $37 | $8.64 | 328.24% |
2023-03-22 | 11 | $52 | $23 | $36.6 | $8.64 | 323.61% |
2023-04-10 | 11 | $52 | $23 | $36.9 | $8.64 | 327.08% |
2023-04-18 | 11 | $52 | $23 | $36.8 | $8.64 | 325.93% |
2023-05-02 | 12 | $43 | $22 | $30.454 | $8.64 | 252.48% |
2023-05-05 | 12 | $42 | $16 | $28.545 | $8.64 | 230.38% |
2023-05-23 | 13 | $42 | $16 | $28.666 | $8.64 | 231.78% |
2023-06-06 | 13 | $42 | $16 | $29.916 | $8.64 | 246.25% |
2023-07-10 | 14 | $42 | $16 | $29.307 | $8.64 | 239.2% |
2023-07-17 | 13 | $42 | $16 | $29.461 | $8.64 | 240.98% |
2023-07-18 | 14 | $41 | $16 | $28.923 | $8.64 | 234.76% |
2023-07-24 | 15 | $41 | $16 | $28.714 | $8.64 | 232.34% |
2023-08-04 | 15 | $41 | $17 | $28.785 | $8.64 | 233.16% |
2023-08-07 | 15 | $41 | $17 | $28.357 | $8.64 | 228.21% |
2023-08-13 | 15 | $41 | $17 | $28 | $8.64 | 224.07% |
2023-08-14 | 15 | $41 | $17 | $27.785 | $8.64 | 221.59% |
2023-08-30 | 15 | $41 | $17 | $27.571 | $8.64 | 219.11% |
2023-09-06 | 15 | $41 | $17 | $27.857 | $8.64 | 222.42% |
2023-09-21 | 15 | $37 | $17 | $26.857 | $8.64 | 210.84% |
2023-09-22 | 15 | $35 | $8 | $20.5 | $8.64 | 137.27% |
2023-10-23 | 15 | $27 | $8 | $16.214 | $8.64 | 87.66% |
2023-11-08 | 15 | $25 | $8 | $15.428 | $8.64 | 78.56% |
2023-11-09 | 15 | $23 | $8 | $15.142 | $8.64 | 75.25% |
2023-11-24 | 15 | $23 | $8 | $14.857 | $8.64 | 71.96% |
2023-12-15 | 16 | $23 | $8 | $14.533 | $8.64 | 68.21% |
2023-12-18 | 16 | $23 | $8 | $14.8 | $8.64 | 71.3% |
The Trend in the Analyst Price Target
TVTX's average price target has moved down $19.75 over the prior 49 weeks.
Over the past 49 weeks, TVTX's average upside potential has been 86.81%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-02-06 | 10 | 50 | 22 | 35.222 | 22.10 | 59.38% |
2023-08-04 | 15 | 41 | 17 | 28.785 | 15.52 | 85.47% |
2023-08-07 | 15 | 41 | 17 | 28.357 | 15.39 | 84.26% |
2023-10-23 | 15 | 27 | 8 | 16.214 | 7.03 | 130.64% |
2023-12-17 | 16 | 23 | 8 | 14.800 | 8.66 | 70.9% |
TVTX Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.5 | 12 | 0 | 4 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
Over the past 14 months, TVTX's average broker recommendation rating worsened by 0.28.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- TVTX has a greater upside potential (average analyst target price relative to current price) than 6419.42% of all US stocks.
- In terms of how TRAVERE THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -5227.62% of that group.
- In the context of stocks in the small market cap category, TRAVERE THERAPEUTICS INC's number of analysts covering the stock is higher than 6738.09% of them.
- TVTX has a greater average analyst price target than 5450.93% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to TRAVERE THERAPEUTICS INC are FBIO, ASMB, and HROW.
View All Top Stocks by Price Target
What is the outlook for TVTX? Use POWR Ratings for clearer insight into price direction.